Amphenol director Rita S. Lane reported a new equity award and updated holdings. She received 1,552 shares of Restricted Stock of Amphenol Corporation on May 22, 2026 as a grant under the 2024 Restricted Stock Plan for Directors, with no purchase price paid.
Following this award, Lane holds 9,840 shares of Class A Common Stock directly and 15,006 shares indirectly through the Fries Lane Family Living Trust, along with the 1,552 restricted shares. This filing reflects a compensation-related acquisition rather than an open-market transaction.
Lamba Sanjiv reported acquisition or exercise transactions in this Form 4 filing.
Amphenol Corporation director Sanjiv Lamba reported an equity compensation grant and his existing share holdings. On May 22, 2026, he received 1,552 shares of Restricted Stock as a grant under the 2024 Restricted Stock Plan for Directors of Amphenol Corporation. A separate line shows he directly holds 548 shares of Class A Common Stock after the reported transactions.
Falck David P reported acquisition or exercise transactions in this Form 4 filing.
Amphenol Corporation director David P. Falck reported a grant of 1,552 shares of Restricted Stock. The award was made on May 22, 2026 at a stated price of $0.00 per share, reflecting stock-based compensation rather than an open-market purchase.
These 1,552 Restricted Stock shares are held directly and were granted under the 2024 Restricted Stock Plan for Directors of Amphenol Corporation. In a separate holding entry, Falck is shown with 94,794 shares of Class A Common Stock held directly following the reported transactions.
Altobello Nancy A. reported acquisition or exercise transactions in this Form 4 filing.
Amphenol Corporation director Nancy A. Altobello received a grant of 1,552 shares of Restricted Stock on Class A Common Stock equivalent on May 22, 2026. The award was granted pursuant to the 2024 Restricted Stock Plan for Directors of Amphenol Corporation.
The Form 4 also reports a holding-line entry showing 18,842 shares of Class A Common Stock held directly after the reported date. There were no open-market purchases or sales disclosed in this filing; the primary activity is a routine compensation-related stock award.
Amphenol Corporation held its annual stockholder meeting on May 21, 2026, with a quorum of 1,121,383,291 shares present out of 1,229,430,709 Class A shares outstanding as of the March 23, 2026 record date. Stockholders elected all eight director nominees with strong majorities; for example, votes for Nancy A. Altobello were 1,060,354,260 for and 12,136,716 against. They also ratified Deloitte & Touche LLP as independent public accountants with 1,048,449,127 votes for, and approved the advisory vote on named executive officer compensation with 984,297,730 votes for.
Amphenol Executive VP & CFO Craig A. Lampo reported estate-planning related changes in his Amphenol holdings. On May 20, 2026, he completed an “other” transaction involving 41,203 shares of Class A Common Stock, leaving 70,907 shares held directly.
On May 19, 2026, he made bona fide gifts of stock options covering 34,499 shares at an exercise price of $86.8800 and 69,108 shares at $65.9550, both tied to Class A Common Stock. A footnote states this reflects a transfer of shares to a family trust for estate planning in exchange for a note, rather than an open-market sale.
Amphenol Corporation executive Lance E. D'Amico reported non-market gift transfers of stock options. On May 20, 2026, he recorded four bona fide gifts of stock options covering a total of 129,188 shares of Amphenol Class A Common Stock, involving both his direct holdings and the Lance E. D'Amico 2024 Irrevocable Trust. The options have exercise prices of $86.88 and $65.955 per share and expire in 2034 and 2035, indicating these are transfers of existing option awards rather than open-market trades.
Amphenol Corporation has issued new euro-denominated senior debt, selling €600,000,000 of 3.375% Senior Notes due 2029 and €500,000,000 of 3.875% Senior Notes due 2034 in an underwritten public offering under its shelf registration.
The company received net proceeds of approximately €1,093.1 million and plans to use this cash to repay borrowings under its U.S. commercial paper program and its 364-day unsecured delayed draw term loan credit agreement, as well as for general corporate purposes. The notes are unsecured senior obligations, pay interest annually starting on May 12, 2027, and may be redeemed early at specified prices, including a make-whole premium before defined dates.
Amphenol Corporation is offering €600,000,000 of 3.375% Senior Notes due 2029 and €500,000,000 of 3.875% Senior Notes due 2034. Interest on both series is payable annually each May 12, beginning May 12, 2027. The notes are unsecured senior obligations that rank equally with Amphenol's other unsecured senior indebtedness and will be denominated and payable in euro. The company expects net proceeds of approximately €1,093.1 million, to be used to repay borrowings under its U.S. commercial paper program and a 364‑Day Delayed Draw Term Loan and for general corporate purposes. The notes may be redeemed under specified optional‑redemption formulas, redeemed upon certain changes in withholding tax treatment at 100%, and holders may require repurchase at 101% of principal if a qualifying Change of Control Repurchase Event occurs. The offering is being conducted under an S-3 shelf process and the notes will be represented by global notes for Euroclear and Clearstream.